Answers are grounded in this paper and cite their sources.
Particularly suitable: An N-terminal serine mutant of anti-HER2 scFv antibody was conjugated to polymer-coated magnetofluorescent nanoparticles by strain-promoted alkyne-nitrone cycloaddition. The resulting nanoparticles (see scheme) proved effective in targeting and labeling HER2-positive breast cancer cells.
No takes yet. Share an insight, caveat, or question.
Colombo et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: